Ceradyne, Inc. (Nasdaq:CRDN) (Company) today reported results for the fourth quarter and twelve months ended December 31, 2005. Sales for the fourth quarter 2005 increased 36.9% to a record $114.2 million from $83.4 million in the fourth quarter of 2004. Net income for the fourth quarter 2005 increased 82.7% to a record $16.1 million, or $.63 per diluted share, compared to net income of $8.8 million, or $.35 per diluted share, in the fourth quarter of 2004. Fourth quarter 2005 net income included a non-recurring, non-cash after tax expense of $1.7 million, or $.07 per diluted share related to the write off of unamortized loan fees resulting from the repayment in full of the Company's 2004 credit facility, which was replaced with a fixed rate convertible bond issued in December 2005. Fully diluted average shares outstanding for the fourth quarter were 25,479,000, compared to 24,823,000 in the same period in 2004. Gross profit margin increased to 36.7% of net sales in the fourth quarter of 2005 from 31.3% of net sales in the fourth quarter of 2004. The provision for income taxes was 34.6% in the fourth quarter 2005, compared to 34.4% in the fourth quarter 2004. Sales for the year ended December 31, 2005, increased to a record $368.3 million, up 70.8% from $215.6 million in 2004. For the year ended December 31, 2005, net income increased to $46.8 million, or $1.86 per diluted share, on 25,107,000 average shares outstanding, from $27.6 million, or $1.12 per diluted share, on 24,598,000 average shares outstanding, for the year ended December 31, 2004. Net income for the year ended December 31, 2005 was up 69.7% over last year, and earnings per diluted share for 2005 increased 66.1% compared to 2004. Fourth quarter 2005 new orders were $200.9 million compared to $145.1 million in fourth quarter 2004. For the year 2005, new orders were $443.6 million compared to $276.0 million in 2004. Total order backlog on December 31, 2005 was $276.4 million compared to the prior year backlog of $199.9 million. Joel P. Moskowitz, Ceradyne chief executive officer, commented: "In addition to the record fourth quarter 2005 operating performance reported above, in December 2005 Ceradyne successfully issued 2,070,000 shares of its common stock and $121,000,000 of a 2 7/8 percent fixed rate convertible bond. After underwriting fees and expenses relating to these concurrent offerings, the Company netted approximately $84.7 million related to the equity portion and $116.8 million related to the convertible bond. We used approximately $118.7 million to retire the floating rate debt we had raised in 2004 related to our acquisition of ESK Ceramics, with the balance of approximately $82.8 million intended for working capital, capital expenditures and other general corporate purposes, and possibly for acquisitions." Ceradyne's management will review the financial results for the quarter and the year ended December 31, 2005, and provide an outlook on Ceradyne's business, including providing updated 2006 guidance, in a conference call at 8 a.m. PST today. Interested parties may listen to the teleconference live via the Internet at www.ceradyne.com or www.Fulldisclosure.com. These web sites will also host an archive of the teleconference. A telephone playback will be available beginning 11:30 a.m. PST today through midnight on March 2, 2006. The playback can be accessed by calling 800-642-1687 (or 706-645-9291 for international callers) and providing Conference ID 4684018. Ceradyne develops, manufactures and markets advanced technical ceramic products and components for defense, industrial, automotive/diesel and commercial applications. Additional information about the Company can be found at www.ceradyne.com. Except for the historical information contained herein, this news release contains forward-looking statements regarding future events and the future performance of Ceradyne that involve risks and uncertainties that could cause actual results to differ materially from those projected. Words such as "anticipates," "believes," "plans," "expects," "intends," "future" and similar expressions are intended to identify forward-looking statements. These risks and uncertainties are described in the Company's supplemental prospectuses, dated December 13, 2005, as filed with the Securities and Exchange Commission. -0- *T Below is a summary of unaudited comparative results. Amounts in thousands except per share data. Three Months Ended Year Ended December 31 December 31 2005 2004 2005 2004 ---- ---- ---- ---- NET SALES $114,153 $83,372 $368,253 $215,612 Cost of product sales 72,290 57,280 237,115 146,518 -------- ------- -------- -------- GROSS PROFIT 41,863 26,092 131,138 69,094 -------- ------- -------- -------- Operating expenses: Selling 5,385 4,694 20,694 8,266 General and Administrative 5,835 5,103 21,014 14,131 Research and Development 2,163 1,460 7,802 3,341 -------- ------- -------- -------- 13,383 11,257 49,510 25,738 -------- ------- -------- -------- INCOME FROM OPERATIONS 28,480 14,835 81,628 43,356 Other income (expense): Other income 326 (167) 854 2,224 Interest (expense) (4,265) (1,279) (9,252) (1,661) -------- ------- -------- -------- (3,939) (1,446) (8,398) 563 INCOME BEFORE PROVISION FOR INCOME TAXES 24,541 13,389 73,230 43,919 Provision for income taxes 8,487 4,604 26,452 16,346 -------- ------- -------- -------- NET INCOME $16,054 $8,785 $46,778 $27,573 ======== ======= ======== ======== Earnings per share, basic $0.64 $0.36 $1.90 $1.14 Earnings per share, diluted $0.63 $0.35 $1.86 $1.12 Avg. shares outstanding, basic 24,944 24,395 24,635 24,170 Avg. shares outstanding, diluted 25,479 24,823 25,107 24,598 Condensed Consolidated Balance Sheets (in thousands): December 31, December 31, 2005 2004 -------- -------- Cash and Cash Equivalents $91,542 $4,521 Short Term Investments 7,839 10,041 Other Current Assets 155,080 120,085 Net Property, Plant and Equipment 153,259 162,278 Other Assets 21,717 19,429 -------- -------- Total Assets $429,437 $316,354 ======== ======== Current Liabilities $40,739 $56,258 Long Term Debt 121,000 108,625 Non Current Liabilities 11,229 10,735 Deferred Tax Liability 6,075 5,695 Stockholders' Equity 250,394 135,041 -------- -------- Total Liabilities and Stockholders Equity $429,437 $316,354 ======== ======== *T
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Ceradyne, Inc. (MM) Charts.
Ceradyne, Inc. (MM) (NASDAQ:CRDN)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Ceradyne, Inc. (MM) Charts.